Filing Details

Accession Number:
0000899243-22-007923
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-25 17:08:41
Reporting Period:
2022-02-23
Accepted Time:
2022-02-25 17:08:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1538927 Forma Therapeutics Holdings Inc. FMTX Biological Products, (No Disgnostic Substances) (2836) 371657129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1814686 D. Frank Lee C/O Forma Therapeutics Holdings, Inc.
300 North Beacon Street, Suite 501
Watertown MA 02472
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-02-23 17,981 $9.78 79,769 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.61 to $10.005. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.